Helen Blaisdell-Brennan
Psychiatry · Honolulu, HINPI 1427063122
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 240 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Alkermes, Inc. at 50.7% of the total. Reporting peaked in 2019 at $1,706 and has fallen 87.0% since, to $222 in 2025. Among psychiatry clinicians in HI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 240 payments — averaging $24.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$3K
- Sunovion Pharmaceuticals Inc.$2K
- Neurocrine Biosciences, Inc.$351
- Otsuka America Pharmaceutical, Inc.$295
- Teva Pharmaceuticals USA, Inc.$267
- AbbVie$132
- plus $130 from 4 others
What the payments were for
- Food & beverage$5,834100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 96 | $2,960 |
| Sunovion Pharmaceuticals Inc. | 87 | $1,701 |
| Neurocrine Biosciences, Inc. | 9 | $351 |
| Otsuka America Pharmaceutical, Inc. | 23 | $295 |
| Teva Pharmaceuticals USA, Inc. | 4 | $267 |
| AbbVie | 12 | $132 |
| Johnson & Johnson | 3 | $53 |
| Lundbeck LLC | 4 | $45 |
| Novo Nordisk | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,834 in reported general payments places this provider in the 95th percentile of 183 psychiatry providers in Hawaii.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Olanzapine | 15 | $297 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 11 | $209 |
| Fluoxetine Hcl | 18 | $69 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Honolulu
- Denis Mee-LeeHonolulu$526K
- David SteinHonolulu$186K
- Gregory YuenHonolulu$6K
- Raymond DavidsonHonolulu$6K
- Glorifin BelmonteHonolulu$5K
- Brett LuHonolulu$5K
- Donna McBrien SliwowskiHonolulu$4K
- Alan BuffensteinHonolulu$3K
- Nancy LuckieHonolulu$3K
- Angela KingHonolulu$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.